Related Experiment Videos
Protocol for a systematic evaluation of pediatric pharmacy development and pediatric pharmacy experts' research area
Hao Li1, Shi-Ying Huang1, Shun-Guo Zhang1
1Department of Pharmacy, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai.
Insights
This study evaluates pediatric pharmacy research in China, revealing regional disparities. An expert database will be created to guide future pediatric pharmacology consensus and policy development.
Area of Science:
- Pharmacology
- Health Services Research
- Pediatrics
Background:
- The current state of pediatric pharmacy research in Chinese children's hospitals remains largely uncharacterized.
- Previous research indicates significant regional variations in the academic standing of tertiary (Grade III Level A) children's hospitals across China.
Purpose of the Study:
- To systematically evaluate the development of pediatric pharmacy and the research landscape of pediatric pharmacy experts in China.
- To establish a comprehensive database of pediatric pharmacy experts to facilitate future consensus-building and policy formulation.
Main Methods:
- A systematic literature search of Chinese and English databases (CNKI, Wanfang, VIP, Medline, EMbase, Cochrane Library) from inception to December 31, 2018.
- Utilizing the Pediatric Pharmacy Development Index (PPDI) and calculation weights (W, ∑W, ∑yearW) to assess hospital development and academic levels.
- Analyzing published literature to determine expert professional fields and constructing an expert database.
Main Results:
- The study will provide an in-depth analysis of pediatric pharmacy development across 23 tertiary children's hospitals in China.
- Identification of the professional backgrounds and research specializations of pediatric pharmacy experts.
- Creation of a structured database of these experts.
Conclusions:
- This research offers a holistic overview of pediatric pharmacy development within China.
- The developed expert database will serve as a crucial resource for achieving consensus in pediatric pharmacology.
Background:
The pediatric pharmacy research status of children's hospitals in China is still unknown. Our previous findings suggest the regional differences in academic level in tertiary (grade III level A) children's hospitals in China.
Methods:
This systemic evaluation described in this protocol will be conducted to follow the Cochrane Handbook. We will perform a systemic literature search of relevant databases including Chinese databases (CNKI, Wanfang Data, VIP Paper Check System) and English databases (Medline, EMbase, Cochrane Library) from inception to December 31, 2018. The search strategy will be enacted according to the guidance offered from the Cochrane Handbook. Two rounds of searches will be conducted to prevent the omission of relevant literature. A pre-set grading standard will be used to give calculation weight (W) to evaluate the quality of each article. Data synthesis will be performed using STATA software (version 13.1, Statacorp, College Station, Texas). Pediatric pharmacy development index (PPDI) of each hospital will be used to evaluate the pediatric pharmacy development in each tertiary children's hospitals. The cumulative calculation weight (∑W) and annual calculation weight (∑yearW) will be used to evaluate the academic level of pharmaceutical departments in different tertiary children's hospitals. Subgroup analysis will be performed to compare the number of different types of articles published between different hospitals base on different research areas such as policy research, basic research, and clinical research.
Results:
In this article, we will evaluate pediatric pharmacy development and the research area of pediatric pharmacy experts in China. Based on the results from this research, we will analyze the professional backgrounds of pediatric pharmacy experts from 23 tertiary children's hospitals in China. According to the contents and research directions of literature published by the pediatric pharmacy experts in these 23 hospitals, we will determine the professional field of pediatric pharmacy experts and establish an expert database. In the process of formulating the related national or local policies in the future, the expert database will be selected accurately to reach the expert consensus.
Conclusion:
Our study will provide a comprehensive picture of pediatric pharmacy development in China. The pediatrics pharmacy expert's database constructed by this study will be used to build consensus on pediatric pharmacology in the future.